Search

Lisa DeAngelis, MD, Chief Physician Executive and Scott M. and Lisa G. Stuart Chair of Memorial Sloan Kettering Cancer Center (MSK), has been named to amNY Metro and PoliticsNY’s Power Players in Healthcare list.

… Wednesday, November 29, 2023 Lisa DeAngelis, MD, Chief Physician Executive and Scott M. and Lisa G. Stuart Chair of Memorial Sloan Kettering Cancer Center (MSK), has been named to  amNY Metro  and  PoliticsNY ’s Power Players in Healthcare list. The list acknowledges and celebrates healthcare leaders

Memorial Sloan Kettering Cancer Center (MSK) has named William F. Pirl, MD, MPH, as the new Chair of the Psychiatry & Behavioral Sciences Department. Dr. Pirl is a nationally and internationally recognized expert and leader in psycho-oncology. He is no stranger to MSK; he completed his fellowship in psycho-oncology at the institution twenty-five years ago.

… Wednesday, June 25, 2025 Memorial Sloan Kettering Cancer Center (MSK) has named William F. Pirl, MD, MPH, as the new Chair of the  Psychiatry & Behavioral Sciences Department . Dr. Pirl is a nationally and internationally recognized expert and leader in psycho-oncology. He is no stranger to MSK; he completed

Memorial Sloan Kettering Cancer Center President Harold Varmus was awarded the 2008 Henry G. Friesen International Prize in Health Research on September 24 in Toronto.

… Monday, December 1, 2008 Summary Memorial Sloan Kettering Cancer Center President Harold Varmus was awarded the 2008 Henry G. Friesen International Prize in Health Research on September 24 in Toronto. Memorial Sloan Kettering Cancer Center President Harold Varmus was awarded the 2008 Henry G. Friesen

Memorial Sloan Kettering Cancer Center (MSK) recently executed a contract with HealthLinx, a consulting firm that helps hundreds of hospitals achieve Magnet® and Pathway to Excellence ® designation. Under the agreement, MSK’s EBP Consulting Service will provide training in MSK’s proprietary evidence-based practice (EBP) methodology directly to select HealthLinx clients who are looking to improve or enculturate EBP.

… Thursday, August 21, 2025 Memorial Sloan Kettering Cancer Center (MSK) recently executed a contract with HealthLinx, a consulting firm that helps hundreds of hospitals achieve Magnet® and Pathway to Excellence ® designation. Under the agreement, MSK’s EBP Consulting Service will provide training in MSK

Babies who are born with severe combined immunodeficiency can be successfully treated with a transplant of blood-forming stem cells, according to experts led by Memorial Sloan Kettering’s Richard O’Reilly.

… Wednesday, July 30, 2014 Babies who are born with severe combined immunodeficiency (SCID) can be successfully treated with a transplant of blood-forming stem cells, according to experts led by Memorial Sloan Kettering’s Richard J. O’Reilly, MD , a world-renowned pioneer in the development of transplant

A team of Memorial Sloan Kettering investigators has reported for the first time a novel strategy to coax human embryonic stem cells (HESCs) to develop into cells that could potentially be used to repair the musculoskeletal system, including bone, cartilage, and muscle.

… Monday, June 25, 2007 Summary A team of Memorial Sloan Kettering investigators has reported for the first time a novel strategy to coax human embryonic stem cells (HESCs) to develop into cells that could potentially be used to repair the musculoskeletal system, including bone, cartilage, and muscle.

When comparing options for immediate breast reconstruction after mastectomy, cost analyses should include patient-reported outcome (PRO) measures, such as BREAST-Q scales and complication rates.

… Friday, March 6, 2020 As we move toward alternative payment models for healthcare in the United States, comparative cost analyses need to include the value to patients. When comparing options for immediate breast reconstruction after mastectomy, cost analyses should include patient-reported outcome (

NYC for MSK will unite New Yorkers and some of the most iconic New York brands to commemorate Memorial Sloan Kettering Cancer Center’s 140th Anniversary.

… Wednesday, May 22, 2024 Memorial Sloan Kettering Cancer Center (MSK) announces the launch of  NYC for MSK , celebrating MSK’s 140th anniversary on May 31, 2024. For one day, New York City’s most iconic brands in fashion, food, toys, and sports will come together to support MSK’s mission of ending cancer

The July 27 MSK Science Spotlight features Immunology Program Chair and Director of the Ludwig Center for Cancer Immunotherapy at MSK, Alexander Rudensky, PhD.

… Monday, July 27, 2020 The July 27 MSK Science Spotlight features Immunology Program Chair and Director of the Ludwig Center for Cancer Immunotherapy at MSK, Alexander Rudensky, PhD . He will be presenting, “A Cell-Extrinsic Mechanism Limiting Immunity and Inflammation.” Dr. Rudensky is an internationally

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Monday, June 15, 2020 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Design and Construction of David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center Recognized by Industry Leaders David H. Koch Center for Cancer Care at Memorial